New inhibitor of POLI (RNA polymerase) CX‐5461 was described to have preferential activity against cancer cells (Bywater et al., 2012) and its efficacy increased in taxane‐resistant OC cells (Cornelison et al., 2017). The gene discussed is POLI; the disease is cancer.